Complement factor 5a receptor chimeras reveal the importance of lipid‐facing residues in transport competence

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The FEBS Journal

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1742-4658.2009.07002.xPMID 19459935PMCID PMC2747494
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lack of Evidence for AT1R/B2R Heterodimerization in COS-7, HEK293, and NIH3T3 Cells

  2009cited by this paper
• Crystal structure of opsin in its G-protein-interacting conformation

  2008cited by this paper
• Complement Component 5a Receptor Oligomerization and Homologous Receptor Down-regulation*

  2008cited by this paper
• Crystal structure of the ligand-free G-protein-coupled receptor opsin

  2008cited by this paper
• Dopamine D2 receptors form higher order oligomers at physiological expression levels

  2008cited by this paper
• Conformational Movement of F251 Contributes to the Molecular Mechanism of Constitutive Activation in the C5a Receptor

  2008cited by this paper
• GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function

  2007cited by this paper
• D1 and D2 Dopamine Receptor Expression Is Regulated by Direct Interaction with the Chaperone Protein Calnexin*

  2007cited by this paper
• High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

  2007cited by this paper
• Constitutive homo- and hetero-oligomerization of TbetaRII-B, an alternatively spliced variant of the mouse TGF-beta type II receptor.

  2006cited by this paper
• Constitutive homo- and hetero-oligomerization of TβRII-B, an alternatively spliced variant of the mouse TGF-β type II receptor

  2006cited by this paper
• The role of GPCR dimerisation/oligomerisation in receptor signalling.

  2006cited by this paper
• Serotonin 5-HT2C Receptor Homodimer Biogenesis in the Endoplasmic Reticulum

  2006cited by this paper
• Molecular mechanisms of constitutive activity: mutations at position 111 of the angiotensin AT1 receptor.

  2005cited by this paper
• Methods to monitor the quaternary structure of G protein‐coupled receptors

  2005cited by this paper
• Essential role for the second extracellular loop in C5a receptor activation

  2005cited by this paper
• G Protein-coupled Receptor Kinases Promote Phosphorylation and β-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers*

  2005cited by this paper
• Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation.

  2005cited by this paper
• Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation.

  2005cited by this paper
• Empirical lipid propensities of amino acid residues in multispan alpha helical membrane proteins

  2005cited by this paper
• Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor

  2005cited by this paper
• Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting*

  2004cited by this paper
• Helix packing moments reveal diversity and conservation in membrane protein structure.

  2004cited by this paper
• Functional consequences of 7TM receptor dimerization.

  2004cited by this paper
• Oligomerization of Wild Type and Nonfunctional Mutant Angiotensin II Type I Receptors Inhibits Gαq Protein Signaling but Not ERK Activation*

  2004cited by this paper
• C5a Receptor Oligomerization I. DISULFIDE TRAPPING REVEALS OLIGOMERS AND POTENTIAL CONTACT SURFACES IN A G PROTEIN-COUPLED RECEPTOR*

  2003cited by this paper
• Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization.

  2003cited by this paper
• Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein.

  2003cited by this paper
• Perturbation of D1 Dopamine and AT1 Receptor Interaction in Spontaneously Hypertensive Rats

  2003cited by this paper
• Human Cytomegalovirus Glycoprotein UL16 Causes Intracellular Sequestration of NKG2D Ligands, Protecting Against Natural Killer Cell Cytotoxicity

  2003cited by this paper
• C5a Receptor Oligomerization

  2003influential reference
• Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin.

  2003cited by this paper
• Oligomerization, Biogenesis, and Signaling Is Promoted by a Glycophorin A-like Dimerization Motif in Transmembrane Domain 1 of a Yeast G Protein-coupled Receptor*

  2003cited by this paper
• Dual Inhibition of &bgr;-Adrenergic and Angiotensin II Receptors by a Single Antagonist: A Functional Role for Receptor–Receptor Interaction In Vivo

  2003cited by this paper
• Three-dimensional model for meta-II rhodopsin, an activated G-protein-coupled receptor.

  2003cited by this paper
• Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis.

  2003cited by this paper
• The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer*

  2003cited by this paper
• C5a Receptor Oligomerization

  2003cited by this paper
• Oligomerization of the α1a- and α1b-Adrenergic Receptor Subtypes

  2003cited by this paper
• C5a Receptor Oligomerization FLUORESCENCE RESONANCE ENERGY TRANSFER STUDIES OF A HUMAN G PROTEIN-COUPLED RECEPTOR EXPRESSED IN YEAST*

  2003cited by this paper
• Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210

  2002cited by this paper
• The Extracellular N-terminal Domain and Transmembrane Domains 1 and 2 Mediate Oligomerization of a Yeast G Protein-coupled Receptor*

  2002cited by this paper
• Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor

  2002cited by this paper
• Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET).

  2002cited by this paper
• Novel approach to computer modeling of seven-helical transmembrane proteins: current progress in the test case of bacteriorhodopsin.

  2001cited by this paper
• The oxytocin receptor system: structure, function, and regulation.

  2001cited by this paper
• Lipid-facing correlated mutations and dimerization in G-protein coupled receptors.

  2001cited by this paper
• Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein

  2001cited by this paper
• The Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist*

  2001cited by this paper
• Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs).

  2001cited by this paper
• AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

  2000cited by this paper
• Uncovering molecular mechanisms involved in activation of G protein-coupled receptors.

  2000cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• A trafficking checkpoint controls GABA(B) receptor heterodimerization.

  2000cited by this paper
• Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).

  2000cited by this paper
• Genetic Mapping of the Human C5a Receptor

  2000influential reference
• C5a Receptor Activation

  1999cited by this paper
• RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

  1998cited by this paper
• Alanine Insertion Scanning Mutagenesis of Lactose Permease Transmembrane Helices*

  1997cited by this paper
• A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation*

  1996cited by this paper
• N-linked glycosylation of the C5a receptor.

  1993cited by this paper
• Topographical requirements for δ‐selective opioid peptides

  1991cited by this paper
• Topographical requirements for delta-selective opioid peptides.

  1991cited by this paper

• Severe Neutropenia in Patients with Chronic Hepatitis C: A Benign Condition

  2012cites this paper
• Structural Basis of M3 Muscarinic Receptor Dimer/Oligomer Formation*

  2011cites this paper